Geron Corporation’s Post

In a comprehensive presentation at the Proactive One2One Investor Conference, ANGLE PLC (AIM:AGL, OTCQX:ANPCY) CEO, Andrew Newland, and CFO, Ian Griffiths, detailed the company's innovative approach to #cancer #diagnosis and #treatment. Newland emphasised ANGLE's breakthrough #technology, the Parsortix system, a groundbreaking instrument designed for separating cancer cells from blood. This British-developed technology provides a viable alternative to traditional biopsies, especially useful as cancer evolves over time, making repeated tissue biopsies impractical. ANGLE PLC (AIM:AGL, OTCQX:ANPCY) has achieved a significant milestone with the only FDA clearance globally for harvesting cancer cells from blood for analysis, taking six and a half years. This clearance serves as a major credibility factor in discussions with potential customers. Watch at #Proactive #ProactiveInvestors http://ow.ly/PmIx1059i2N #AIM #OTCQX #AGL #ANPCY

Veru Inc.( $VERU) Advances Muscle Preservation Research with Enobosarm and Strengthens Financial Position https://lnkd.in/eJTqk_CR #stockstowatch #stocksinnews #investors #daytrader #PrismMarketView #PrismMediaWire #PrismDigitalMedia

It is really inspirational to work in an environment where people solve not only important but existential problems. Change one "letter" in your DNA code, and change your life. The gene therapy toolbox offers a new era of "antibiotics" and methods to cure severe diseases like cancer. In some cases, gene therapy may restore sight to the blind and enable the deaf to hear. Hearing about Dr. Jennifer Johnston's from NySnoBio efforts to use gene therapy to cure young people with Parkinson's disease fills us with hope. While gene therapy may not help everyone, it is undeniably a game-changer for mankind. Consider this... With gene therapy, we could develop new "antibiotics" that make resistant bacteria visible to our immune system or susceptible to antibiotics once again. This approach is already ongoing. Additionally, we could treat life-threatening brain cancer like glioblastoma or breast cancer using possible gene therapy tools, such as those developed by Dr. Evy Lundgren-Åkerman from Xintela/Targinta (https://lnkd.in/dkpFgkK6). This brings hope to many people...... thank you! #genetherapy #drugdelivery #smartmedicine #trutags

Join us for our Great Debates and Updates meeting series covering both solid and liquid tumor topics throughout the year! Engage in thoughtful discussions with your peers to improve patient care and outcomes. Our meetings are a great opportunity to connect, learn and grow! Check out the dates for our meetings for the remainder of the year: - Great Debates & Updates Hematological Malignancies: April 5-6- NYC - Great Debates & Updates in Lung Cancer : April 27-28- NYC - Great Debates & Updates in Women's Oncology: May 3-4, NYC - Great Debates & Updates Hem/Myeloma Day: May 11 - Dallas - Great Debates & Updates in GI Malignancies: May 17-18 - NYC - Great Debates & Updates Hematological Malignancies: July 27 -28 - Los Angeles - Great Debates & Updates in Lung Cancer : October 5-6 - Dallas - Great Debates & Updates in GI Malignancies: October 19-20 - Dallas - Great Debates & Updates in Women's Oncology: November 1-2 - Nashville If you're interested in attending any of these meetings or need additional information regarding commercial sponsorships, let me know! #oncology #patientcare #healthcare #medicalconference #greatdebates&updates #GDU Great Debates & Updates

🌟 Did you miss the pre-application webinar for LLS's Equity in Access Research Program? Catch the replay! We had an incredible session where LLS staff provided an overview and answered questions on our current RFP, "Building Evidence for Effective Interventions to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups." If you couldn't join us live, now's your chance to catch up! 🎥 Watch the full webinar here: https://lnkd.in/eK6hHxup We've also compiled a list of frequently asked questions along with our responses. You can find the FAQ document here: https://lnkd.in/eEiBp3Nt 📢 Don't miss out: Whether you're a researcher interested in applying for this funding opportunity or want to learn more about LLS's efforts to increase clinical trial enrollment, this webinar is packed with valuable information. Stay tuned for more updates coming soon on our website! https://lnkd.in/eV3UPSHf

Today our investor community has lost yet another friend to cancer. Beyond the loss and deep sadness, all healthcare investors should be PROUD : business angels , family offices, vc funds, you bring your brick to the potential emergence of solutions that will bring hope to patients and their families; Never forget that the investment journey is about saving lives. Your expertise and your money are invaluable in this quest. So investors, continue to carry the light down the sometimes long and treacherous path. Have faith for those who have lost theirs This is for you Trudi Haemmerli, Swiss Health Angels - Business Angel Association, Angels Santé, EBAN - European Business Angel Network, Ala Alenazi, René Reijtenbagh,Hans-Joachim Diedenhofen,Guillaume AmblardAlain Pujol,

Informational Webinar: August 22; Proposals Due: October 18 Topics for FY25: -Novel Delivery Systems for RNA-based Cancer Vaccines -Development of Cancer Immunoprevention Agents -Synthetic Microbes (Excluding Oncolytic Viruses) for Immuno-Oncology Therapies -Development of Novel Therapeutics for HPV-related Precancer -Precision Nutrition Interventions to Reduce Cancer-Related Symptoms -Drug-Loaded Carrier Particles for Improved Oral Delivery for Colon Cancer Prevention -Antibody-Drug Conjugates as Radiopharmaceutical Theranostics for Cancer -Point of Care Detection of Antibodies Against HPV16/18 E6 and E7 Oncoproteins in Oropharyngeal Cancer -Point of Care Technologies for GI Cancer Prevention and Early Detection -Development of Digital Biomarkers and Endpoints for Clinical Cancer Care -Digital Twin Software for Optimization of Cancer Radiation Therapy  -Wearable Technologies to Facilitate Remote Monitoring of Cancer Patients Following Treatment -Advanced Biomaterials to Improve Cancer Modeling for Research

June Issue of Strategies Oncology magazine - Solid information for Smart Decisions- The theme this month is Assessing Cancer Drugs: Ongoing Challenges As usual, Strategies offers different perspectives on important issues. In This Issue: -Advocating for Patients Over Profits: Profit-Driven Medicine Limits Patient Access to Critical Cancer Treatments -Breakthrough Treatments are Coming to Market Practically Every Day: But the Question is, "How Much Do They Cost?" -The Impact of Pharmacy Benefit Managers on Oncology Treatment Pharmaceutical Manufacturer Patient Assistance Programs: One Answer to High Drug Costs for Patients -Analyzing Financial Challenges and Best Practices to Improve Cancer Care -----Plus Regular Features: Corporate Members Patient Assistance List Oncology News Links Valuable COVID-19 Resources Strategies Editorial Calendar Insights Launch Page. #STRATEGIESONCOLOGYMAGAZINE #ONCOLOGY #profitdrivendrugs #BREAKTHROUGHTREATMNENT #PBM #patientassistanceprograms #cancercare #medicalsoftware https://lnkd.in/gDuDVrbi

📰 Year in Review: 2023 - A Year of Growth and Partnerships 🌟 As we wrap up the year, let's reflect on 2023—a year marked by growth and exciting new partnerships. Our latest blog delves into the milestones, collaborations, and strides we've made in advancing our mission. https://lnkd.in/eAzVZTjd #YearInReview #Growth #NewPartnerships